The ICMR analysis found that the BPaL regimen is "both more effective and cost-saving" compared to the current standard of ...

Researchers at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo have developed a new ...

A study comparing one- and three-month antibiotic treatments to prevent active tuberculosis (TB) finds that a high percentage ...

In the wake of a recent outbreak of tuberculosis (TB) and latent TB cases at a local San Francisco high school, IGHS's Priya ...

Shorter, six month and alloral treatment regimens for multidrugresistant and rifampicinresistant tuberculosis (MDR/RRTB) are ...

A phase 4 trial in Brazil finds 1-month and 3-month treatment regimens are safe and effective options for preventing active ...

Antibiotic treatments are losing effectiveness against a range of common bacterial pathogens, including E. coli, K.

A study comparing one- and three-month antibiotic treatments to prevent active tuberculosis (TB) finds that a high percentage ...

Sepsis is a leading global cause of hospital deaths, occurring when the body’s response to infection damages tissue and ...

Major trial finds immediate or high-dose TB treatment does not lower overall mortality in HIV-related sepsis, except in ...

Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.